On the contrary, the combination of Dox:Mcl-1 siRNA stunted the growth of the spheroid at an early time point and markedly shrunk the tumor spheroid at a later time point, indicating that the Dox:Mcl-1 siRNA combination treatment was more effective in breast tumorsphere inhibition than the single treatment of each individual agent. Here, MCL1 is linked to neoplasm.